Of those, GRO remained associated with dysplasia (OR: 0.64, 95%CI: 0.45–0.91) and BCA‐1 was borderline associated (OR: 0.74, 95%CI: 0.54–1.01) after adjusting the logistic regression model for sex, age, and NSAIDs. Here, CXCL13 is linked to dysplasia.